Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Proteomics

Proteomics

A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

European Myeloma Network Group review and consensus statement on primary plasma cell leukemia.

Annals of oncology : official journal of the European Society for Medical Oncology·2025

Same author

Beyond the marrow: insights from comprehensive next-generation sequencing of extramedullary multiple myeloma tumors.

Leukemia·2024

Same author

Corrigendum to "Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up'": [Ann Oncol Volume 33, Issue 1, January 2022, Page 117].

Annals of oncology : official journal of the European Society for Medical Oncology·2022

Same author

Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus.

ESMO open·2022

Same author

Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up': [Ann Oncol 2021; 32(3): 309-322].

Annals of oncology : official journal of the European Society for Medical Oncology·2021

Same author

Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up<sup>†</sup>.

Annals of oncology : official journal of the European Society for Medical Oncology·2021

Search research articles

Related Experiment Video

Updated: Jul 12, 2026

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Published on: February 27, 2015

[Proteomics techniques and their application in haemato-oncologic malignancies].

J Zelená¹, R Hájek

¹Laborator experimentálni hematologie a bunecné imunoterapie, Oddelení klinicke hematologie FN, Brno-Bohunice. jzelena@fnbrno.cz

Casopis Lekaru Ceskych

|August 29, 2007

Summary

Proteomics offers vital insights into blood cancers by identifying new drug resistance markers and diagnostic biomarkers. This protein-level understanding aids in predicting treatment response and developing targeted therapies for hematological malignancies.

More Related Videos

Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification

Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification

Published on: November 15, 2017

Unveiling Histone Proteoforms using 2D-TAU Gel Electrophoresis

Unveiling Histone Proteoforms using 2D-TAU Gel Electrophoresis

Published on: October 18, 2024

Related Experiment Videos

Last Updated: Jul 12, 2026

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Published on: February 27, 2015

Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification

Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification

Published on: November 15, 2017

Unveiling Histone Proteoforms using 2D-TAU Gel Electrophoresis

Unveiling Histone Proteoforms using 2D-TAU Gel Electrophoresis

Published on: October 18, 2024

Area of Science:

Proteomics
Molecular Biology
Hematology

Context:

Understanding the molecular pathogenesis of hematological malignancies is crucial for effective treatment and diagnostics.
Proteomics, the study of the entire proteome, utilizes technologies like mass spectrometry and Western blotting.
Current research in hematological malignancies using proteomics is limited but shows significant potential.

Purpose:

To review proteomics techniques used in hematological malignancy research.
To highlight key findings from proteomic studies in multiple myeloma, leukaemias, and lymphomas.
To underscore the potential of proteomics in discovering novel biomarkers for drug resistance and diagnostics.

Summary:

Proteomics provides a protein-level view of hematological malignancies, aiding in understanding disease mechanisms.
Techniques such as mass spectrometry are employed to analyze cellular proteomes.
Studies have identified potential biomarkers for drug resistance and diagnostic applications in blood cancers.

Impact:

Proteomics can lead to the discovery of novel therapeutic targets and personalized treatment strategies.
Identification of biomarkers may facilitate the development of rapid diagnostic tests for clinical use.
Advancements in proteomic research can improve patient outcomes in hematological malignancies.